The third version of the Marijuana Opportunity Reinvestment and
Expungement, or MORE, Act was introduced on May 28.
Most importantly, this is a descheduling bill, and descheduling
is the only way in which we comprehensively address the social
justice inequities that exist and the federal-state conflict that
persists in the cannabis industry.
Although potentially a boost to the nation's growing
cannabis industry, the draft bill contains numerous gaps that are
problematic from a business perspective.
These include a lack of clarity as to a regulatory framework
that encompasses both state and federal authority, a failure to lay
out a specific role for the U.S. Food and Drug Administration, and
virtually no consideration for the challenges of interstate
commerce and importations.
